AllianceBernstein’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,497,112
Closed -$10.6M 3258
2024
Q4
$10.6M Buy
3,497,112
+236,641
+7% +$719K ﹤0.01% 1157
2024
Q3
$16.9M Buy
3,260,471
+3,139,751
+2,601% +$16.3M 0.01% 965
2024
Q2
$310K Buy
120,720
+30,220
+33% +$77.7K ﹤0.01% 2903
2024
Q1
$445K Sell
90,500
-500
-0.5% -$2.46K ﹤0.01% 2631
2023
Q4
$800K Hold
91,000
﹤0.01% 2385
2023
Q3
$1.04M Sell
91,000
-2,505,263
-96% -$28.7M ﹤0.01% 2215
2023
Q2
$65.7M Buy
2,596,263
+617,706
+31% +$15.6M 0.03% 501
2023
Q1
$63.7M Buy
1,978,557
+1,894,157
+2,244% +$61M 0.03% 498
2022
Q4
$1.56M Sell
84,400
-32,047
-28% -$592K ﹤0.01% 2055
2022
Q3
$3.14M Hold
116,447
﹤0.01% 1612
2022
Q2
$1.61M Sell
116,447
-27,500
-19% -$380K ﹤0.01% 2079
2022
Q1
$2.81M Buy
143,947
+200
+0.1% +$3.9K ﹤0.01% 1884
2021
Q4
$2.35M Sell
143,747
-3,137,848
-96% -$51.2M ﹤0.01% 2029
2021
Q3
$91.4M Buy
3,281,595
+193,929
+6% +$5.4M 0.04% 449
2021
Q2
$91.5M Sell
3,087,666
-265,613
-8% -$7.87M 0.04% 457
2021
Q1
$93.7M Buy
3,353,279
+287,375
+9% +$8.03M 0.04% 419
2020
Q4
$86.9M Buy
3,065,904
+462,388
+18% +$13.1M 0.04% 417
2020
Q3
$65.5M Sell
2,603,516
-189,294
-7% -$4.76M 0.04% 467
2020
Q2
$68.2M Buy
2,792,810
+580,637
+26% +$14.2M 0.04% 445
2020
Q1
$32.7M Buy
2,212,173
+261,198
+13% +$3.87M 0.02% 550
2019
Q4
$31.7M Sell
1,950,975
-122,236
-6% -$1.98M 0.02% 670
2019
Q3
$27M Buy
2,073,211
+29,411
+1% +$382K 0.02% 690
2019
Q2
$26.5M Buy
2,043,800
+2,671
+0.1% +$34.6K 0.02% 706
2019
Q1
$32.2M Buy
2,041,129
+479,937
+31% +$7.56M 0.02% 659
2018
Q4
$31.4M Sell
1,561,192
-90,757
-5% -$1.83M 0.02% 617
2018
Q3
$41.1M Buy
1,651,949
+341,896
+26% +$8.5M 0.03% 592
2018
Q2
$36M Buy
1,310,053
+170,942
+15% +$4.69M 0.03% 618
2018
Q1
$35.1M Buy
1,139,111
+231,416
+25% +$7.13M 0.03% 597
2017
Q4
$32.5M Buy
907,695
+885,895
+4,064% +$31.7M 0.02% 622
2017
Q3
$601K Sell
21,800
-2,200
-9% -$60.7K ﹤0.01% 2495
2017
Q2
$634K Hold
24,000
﹤0.01% 2498
2017
Q1
$499K Sell
24,000
-3,800
-14% -$79K ﹤0.01% 2521
2016
Q4
$575K Sell
27,800
-1,600
-5% -$33.1K ﹤0.01% 2497
2016
Q3
$477K Sell
29,400
-5,900
-17% -$95.7K ﹤0.01% 2538
2016
Q2
$480K Buy
35,300
+10,000
+40% +$136K ﹤0.01% 2528
2016
Q1
$442K Hold
25,300
﹤0.01% 2447
2015
Q4
$864K Buy
25,300
+3,100
+14% +$106K ﹤0.01% 2200
2015
Q3
$661K Buy
22,200
+2,300
+12% +$68.5K ﹤0.01% 2369
2015
Q2
$636K Buy
19,900
+12,700
+176% +$406K ﹤0.01% 2491
2015
Q1
$149K Sell
7,200
-568,706
-99% -$11.8M ﹤0.01% 2918
2014
Q4
$9.76M Buy
575,906
+60,292
+12% +$1.02M 0.01% 889
2014
Q3
$9.97M Buy
515,614
+141,693
+38% +$2.74M 0.01% 873
2014
Q2
$12.7M Buy
+373,921
New +$12.7M 0.01% 817